Seres Therapeutics, Inc. (MCRB): SC 13D/A filed Oct 2, 2024

Form type

SC 13D/A

Filing date

Oct 2, 2024

Accession number

0001193125-24-230718

Filer

Seres Therapeutics, Inc. (CIK 1609809)